Annual CFO
-$414.33 M
-$114.82 M-38.33%
31 December 2023
Summary:
Cytokinetics Incorporated annual cash flow from operations is currently -$414.33 million, with the most recent change of -$114.82 million (-38.33%) on 31 December 2023. During the last 3 years, it has fallen by -$423.28 million (-4733.04%). CYTK annual CFO is now -1220.36% below its all-time high of $36.98 million, reached on 31 December 2016.CYTK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$101.50 M
-$2.19 M-2.20%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly cash flow from operations is currently -$101.50 million, with the most recent change of -$2.19 million (-2.20%) on 30 September 2024. Over the past year, it has dropped by -$5.29 million (-5.50%). CYTK quarterly CFO is now -230.41% below its all-time high of $77.83 million, reached on 31 December 2016.CYTK Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$404.36 M
-$5.29 M-1.33%
30 September 2024
Summary:
Cytokinetics Incorporated TTM cash flow from operations is currently -$404.36 million, with the most recent change of -$5.29 million (-1.33%) on 30 September 2024. Over the past year, it has increased by +$34.13 million (+7.78%). CYTK TTM CFO is now -1193.39% below its all-time high of $36.98 million, reached on 31 December 2016.CYTK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.3% | -5.5% | +7.8% |
| 3 y3 years | -4733.0% | -161.8% | -786.1% |
| 5 y5 years | -309.4% | -400.8% | -380.4% |
CYTK Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4733.0% | at low | -278.6% | +21.6% | -786.1% | +7.8% |
| 5 y | 5 years | -4733.0% | at low | -294.6% | +21.6% | -4330.1% | +7.8% |
| alltime | all time | -1220.4% | at low | -230.4% | +21.6% | -1193.4% | +7.8% |
Cytokinetics Incorporated Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$101.50 M(+2.2%) | -$404.36 M(+1.3%) |
| June 2024 | - | -$99.31 M(-23.3%) | -$399.06 M(-5.3%) |
| Mar 2024 | - | -$129.51 M(+74.9%) | -$421.55 M(+1.7%) |
| Dec 2023 | -$414.33 M(+38.3%) | -$74.04 M(-23.0%) | -$414.33 M(-5.5%) |
| Sept 2023 | - | -$96.20 M(-21.0%) | -$438.49 M(+2.9%) |
| June 2023 | - | -$121.81 M(-0.4%) | -$426.32 M(+7.9%) |
| Mar 2023 | - | -$122.29 M(+24.5%) | -$394.99 M(+31.9%) |
| Dec 2022 | -$299.52 M(+110.2%) | -$98.19 M(+16.8%) | -$299.52 M(+21.7%) |
| Sept 2022 | - | -$84.04 M(-7.1%) | -$246.06 M(+22.5%) |
| June 2022 | - | -$90.47 M(+237.5%) | -$200.79 M(+43.6%) |
| Mar 2022 | - | -$26.81 M(-40.1%) | -$139.81 M(-1.9%) |
| Dec 2021 | -$142.52 M(-1693.7%) | -$44.74 M(+15.4%) | -$142.52 M(+212.3%) |
| Sept 2021 | - | -$38.77 M(+31.4%) | -$45.63 M(-708.3%) |
| June 2021 | - | -$29.50 M(-0.1%) | $7.50 M(-21.5%) |
| Mar 2021 | - | -$29.52 M(-156.6%) | $9.56 M(+6.9%) |
| Dec 2020 | $8.94 M(-109.8%) | $52.15 M(+263.0%) | $8.94 M(-114.4%) |
| Sept 2020 | - | $14.37 M(-152.4%) | -$62.26 M(-35.7%) |
| June 2020 | - | -$27.44 M(-8.9%) | -$96.90 M(+2.9%) |
| Mar 2020 | - | -$30.14 M(+58.1%) | -$94.14 M(+3.6%) |
| Dec 2019 | -$90.91 M(-10.2%) | -$19.05 M(-6.0%) | -$90.91 M(+8.0%) |
| Sept 2019 | - | -$20.27 M(-17.9%) | -$84.18 M(-12.4%) |
| June 2019 | - | -$24.68 M(-8.3%) | -$96.15 M(-2.2%) |
| Mar 2019 | - | -$26.91 M(+118.3%) | -$98.31 M(-2.9%) |
| Dec 2018 | -$101.22 M(-0.5%) | -$12.33 M(-61.8%) | -$101.22 M(-10.4%) |
| Sept 2018 | - | -$32.23 M(+20.1%) | -$112.96 M(+6.4%) |
| June 2018 | - | -$26.85 M(-9.9%) | -$106.21 M(-4.0%) |
| Mar 2018 | - | -$29.81 M(+23.8%) | -$110.62 M(+8.7%) |
| Dec 2017 | -$101.76 M(-375.2%) | -$24.07 M(-5.5%) | -$101.76 M(<-9900.0%) |
| Sept 2017 | - | -$25.48 M(-18.5%) | $141.00 K(-99.0%) |
| June 2017 | - | -$31.26 M(+49.3%) | $13.50 M(-59.7%) |
| Mar 2017 | - | -$20.94 M(-126.9%) | $33.55 M(-9.3%) |
| Dec 2016 | $36.98 M(+657.4%) | $77.83 M(-742.0%) | $36.98 M(-172.8%) |
| Sept 2016 | - | -$12.12 M(+8.1%) | -$50.79 M(+3.6%) |
| June 2016 | - | -$11.22 M(-35.9%) | -$49.01 M(+4.3%) |
| Mar 2016 | - | -$17.51 M(+76.1%) | -$46.98 M(-1062.2%) |
| Dec 2015 | $4.88 M(-110.9%) | -$9.94 M(-3.9%) | $4.88 M(-27.1%) |
| Sept 2015 | - | -$10.35 M(+12.6%) | $6.70 M(-11.1%) |
| June 2015 | - | -$9.19 M(-126.7%) | $7.53 M(+2.6%) |
| Mar 2015 | - | $34.36 M(-522.6%) | $7.34 M(-116.4%) |
| Dec 2014 | -$44.84 M | -$8.13 M(-14.6%) | -$44.84 M(-8.7%) |
| Sept 2014 | - | -$9.52 M(+1.5%) | -$49.14 M(+67.6%) |
| June 2014 | - | -$9.38 M(-47.4%) | -$29.32 M(+120.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$17.82 M(+43.4%) | -$13.32 M(+72.6%) |
| Dec 2013 | -$7.72 M(-76.9%) | -$12.43 M(-220.6%) | -$7.72 M(+219.9%) |
| Sept 2013 | - | $10.31 M(+55.6%) | -$2.41 M(-88.8%) |
| June 2013 | - | $6.62 M(-154.2%) | -$21.60 M(-41.5%) |
| Mar 2013 | - | -$12.22 M(+71.6%) | -$36.92 M(+10.4%) |
| Dec 2012 | -$33.44 M(-26.7%) | -$7.12 M(-19.8%) | -$33.44 M(-10.3%) |
| Sept 2012 | - | -$8.88 M(+2.1%) | -$37.26 M(-1.0%) |
| June 2012 | - | -$8.70 M(-0.4%) | -$37.65 M(-9.2%) |
| Mar 2012 | - | -$8.74 M(-20.2%) | -$41.45 M(-9.1%) |
| Dec 2011 | -$45.59 M(+1.7%) | -$10.95 M(+18.1%) | -$45.59 M(+4.2%) |
| Sept 2011 | - | -$9.26 M(-25.9%) | -$43.74 M(-2.4%) |
| June 2011 | - | -$12.51 M(-2.9%) | -$44.79 M(-1.6%) |
| Mar 2011 | - | -$12.88 M(+41.7%) | -$45.50 M(+1.5%) |
| Dec 2010 | -$44.83 M(-632.7%) | -$9.09 M(-11.9%) | -$44.83 M(+6.5%) |
| Sept 2010 | - | -$10.32 M(-21.9%) | -$42.09 M(-2.9%) |
| June 2010 | - | -$13.21 M(+8.2%) | -$43.34 M(-642.0%) |
| Mar 2010 | - | -$12.21 M(+92.4%) | $8.00 M(-5.0%) |
| Dec 2009 | $8.42 M(-113.7%) | -$6.35 M(-45.1%) | $8.42 M(+398.0%) |
| Sept 2009 | - | -$11.57 M(-130.3%) | $1.69 M(-150.9%) |
| June 2009 | - | $38.12 M(-423.4%) | -$3.32 M(-94.4%) |
| Mar 2009 | - | -$11.79 M(-9.8%) | -$59.29 M(-3.3%) |
| Dec 2008 | -$61.33 M(+1940.9%) | -$13.07 M(-21.1%) | -$61.33 M(-1.6%) |
| Sept 2008 | - | -$16.58 M(-7.2%) | -$62.29 M(+11.3%) |
| June 2008 | - | -$17.86 M(+29.2%) | -$55.96 M(+8.5%) |
| Mar 2008 | - | -$13.82 M(-1.5%) | -$51.56 M(+1615.7%) |
| Dec 2007 | -$3.00 M(-93.6%) | -$14.04 M(+37.0%) | -$3.00 M(+40.5%) |
| Sept 2007 | - | -$10.25 M(-23.8%) | -$2.14 M(-39.8%) |
| June 2007 | - | -$13.45 M(-138.7%) | -$3.55 M(+144.8%) |
| Mar 2007 | - | $34.73 M(-363.7%) | -$1.45 M(-96.9%) |
| Dec 2006 | -$47.17 M(+19.5%) | -$13.17 M(+12.9%) | -$47.17 M(+7.0%) |
| Sept 2006 | - | -$11.66 M(+2.8%) | -$44.09 M(+7.1%) |
| June 2006 | - | -$11.35 M(+3.3%) | -$41.17 M(-1.7%) |
| Mar 2006 | - | -$10.99 M(+8.9%) | -$41.87 M(+6.0%) |
| Dec 2005 | -$39.48 M(+16.0%) | -$10.09 M(+15.4%) | -$39.48 M(-3.6%) |
| Sept 2005 | - | -$8.75 M(-27.4%) | -$40.97 M(-0.1%) |
| June 2005 | - | -$12.04 M(+40.0%) | -$41.01 M(+15.2%) |
| Mar 2005 | - | -$8.60 M(-25.7%) | -$35.61 M(+4.6%) |
| Dec 2004 | -$34.03 M(+10.9%) | -$11.58 M(+31.8%) | -$34.03 M(+51.6%) |
| Sept 2004 | - | -$8.79 M(+32.2%) | -$22.45 M(+64.3%) |
| June 2004 | - | -$6.65 M(-5.3%) | -$13.67 M(+94.7%) |
| Mar 2004 | - | -$7.02 M | -$7.02 M |
| Dec 2003 | -$30.70 M(+37.6%) | - | - |
| Dec 2002 | -$22.30 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CFO year-on-year change?
- What is Cytokinetics Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CFO year-on-year change?
- What is Cytokinetics Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CFO year-on-year change?
What is Cytokinetics Incorporated annual cash flow from operations?
The current annual CFO of CYTK is -$414.33 M
What is the all time high annual CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual cash flow from operations is $36.98 M
What is Cytokinetics Incorporated annual CFO year-on-year change?
Over the past year, CYTK annual cash flow from operations has changed by -$114.82 M (-38.33%)
What is Cytokinetics Incorporated quarterly cash flow from operations?
The current quarterly CFO of CYTK is -$101.50 M
What is the all time high quarterly CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly cash flow from operations is $77.83 M
What is Cytokinetics Incorporated quarterly CFO year-on-year change?
Over the past year, CYTK quarterly cash flow from operations has changed by -$5.29 M (-5.50%)
What is Cytokinetics Incorporated TTM cash flow from operations?
The current TTM CFO of CYTK is -$404.36 M
What is the all time high TTM CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM cash flow from operations is $36.98 M
What is Cytokinetics Incorporated TTM CFO year-on-year change?
Over the past year, CYTK TTM cash flow from operations has changed by +$34.13 M (+7.78%)